SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Synta Pharmaceuticals
SNTA 0.343+26.6%Jul 22 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (5)2/8/2007 2:31:30 PM
From: keokalani'nui  Read Replies (1) of 112
 
Well, they had a couple rounds before oral anti-il12/23 flamed out in crohns and psoriasis. From what I can tell they pulled the IPO last year at a much higher valuation thinking those results would be positive. The target es muy caliente. But the cpd flopped and probably will for RA too. So, today the price may look better but the clinical program looks really different (hsp70 in mm showed itself better than expected I suspect).

Worth having a syta board at any rate.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News